Partnership of oncoFISH
Cervical with
December 2009
Announced: December 2009Closed: December 2009
Headquarters: New Haven, CT
Chairman of the Board and Chief Executive Officer: Petros Tsipouras
President: Paul White
Chief Technology Officer and Founder: Triantafyllos Tafas
Board of Directors: Petros Tsipouras, Timothy Corcoran, Stefano Ferrari, Andrew Fink, Marco Prete, Howard Rowe, Fulvio Renoldi Bracco, Hadar Ron
Since its founding in 1999, Ikonisys has developed and refined its CellOptics platform, the foundation for Ikonisys’ products and services, enabling the transformation of current non-invasive cell-based diagnostics to future rare cell detection. These products enable large and regional reference laboratories, hospitals, research institutions and practice groups to reduce the risk of human error, lower costs and expand test volume capacity, even during an industry-wide shortage of trained technical personnel. Through its integration of intelligent imaging, microscopy, biology and informatics, Ikonisys is laying the foundation for detecting a single cell and identifying its molecular signals, a long-term key to maximizing patient health and wellness. Acting as exclusive strategic licensing advisor, Torreya helped Ikonisys evaluate multiple strategic options for the company’s product offerings. Ultimately, Ikonisys entered into an exclusive marketing partnership with Enzo Biochem relating to the company’s oncoFISH cervical test, a laboratory developed test for cervical cancer prevention.
Copyright © 2010 Torreya Partners LLC. All rights reserved.
Securities offered through Financial West Group, member FINRA/SIPC. Torreya Partners LLC and Financial West Group are unaffiliated entities.